Research output per year
Research output per year
Personal profile
Headline
PROFESSOR Medicine, Infectious Diseases
Biography
Fingerprint
Dive into the research topics where Judith Aberg is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Changes in Body Mass Index with Longer-Term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE)
Kileel, E. M., Malvestutto, C. D., Lo, J., Fitch, K. V., Fichtenbaum, C. J., Aberg, J. A., Zanni, M. V., Martinez, E., Okeke, N. L., Kumar, P., Joao, E., Bares, S. H., Berrner, D., Smieja, M., Roa, J. C., McCallum, S., Douglas, P. S., Ribaudo, H. J. & Grinspoon, S. K., 1 Jun 2023, In: Clinical Infectious Diseases. 76, 11, p. 2010-2013 4 p.Research output: Contribution to journal › Article › peer-review
-
Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People with Treated Human Immunodeficiency Virus
Schnittman, S. R., Kitch, D. W., Swartz, T. H., Burdo, T. H., Fitch, K. V., McCallum, S., Flynn, J. M., Fulda, E. S., Diggs, M. R., Stapleton, J. T., Casado, J. L., Taron, J., Currier, J. S., Zanni, M. V., Malvestutto, C., Fichtenbaum, C. J., Aberg, J. A., Ribaudo, H. J., Lu, M. T., Douglas, P. S., & 1 others, 1 Mar 2023, In: Open Forum Infectious Diseases. 10, 3, ofad106.Research output: Contribution to journal › Article › peer-review
Open Access -
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)
Schnittman, S. R., Lu, M. T., Mayrhofer, T., Burdo, T. H., Fitch, K. V., McCallum, S., Fulda, E. S., Zanni, M. V., Foldyna, B., Malvestutto, C., Fichtenbaum, C. J., Aberg, J. A., Bloomfield, G. S., Overton, E. T., Currier, J., Tebas, P., Sha, B. E., Ribaudo, H. J., Flynn, J. M., Douglas, P. S., & 2 others, 1 Feb 2023, In: Clinical Infectious Diseases. 76, 3, p. E613-E621Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV
Schnittman, S. R., Jung, W., Fitch, K. V., Zanni, M. V., McCallum, S., Lee, J. S. L., Shin, S., Davis, B. J., Fulda, E. S., Diggs, M. R., Giguel, F., Chinchay, R., Sheth, A. N., Fichtenbaum, C. J., Malvestutto, C., Aberg, J. A., Currier, J., Lauffenburger, D. A., Douglas, P. S., Ribaudo, H. J., & 2 others, 8 Mar 2023, In: JCI insight. 8, 5, e166848.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Evaluating the effect of atorvastatin exposure and vitamin D levels on lipid outcomes in people with HIV-1 with suppressed HIV-1 RNA and LDL cholesterol <130 mg/dL
Rahman, F., Brates, I., Aweeka, F., Bosch, R. J., Deitchman, A., Nixon, D. & Aberg, J. A., Jun 2023, In: HIV Medicine. 24, 6, p. 749-753 5 p.Research output: Contribution to journal › Article › peer-review
Press/Media
-
Rukobia Still Effective at Five Years for People With Highly Resistant HIV
8/11/23
1 item of Media coverage
Press/Media
-
Reports from Icahn School of Medicine at Mount Sinai Highlight Recent Findings in HIV/AIDS (Brief Report: Hepatitis B Infection or Reactivation After Switch To 2-drug Antiretroviral Therapy: a Case Series, Literature Review, and Management ...)
Michael P. Mullen, Douglas Dieterich & Judith Aberg
26/10/23
1 item of Media coverage
Press/Media
-
Mount Sinai Hospital: CastleVax Receives BARDA Project NextGen Award Valued at Up to $338M to Advance Intranasal NDV-Based COVID-19 Booster Vaccine Into Phase 2b Clinical Efficacy Testing
Florian Krammer, Peter Palese, Adolfo Garcia-Sastre, Judith Aberg, Weina Sun & Sean T.H. Liu
19/10/23
1 item of Media coverage
Press/Media
-
Mount Sinai: CastleVax Receives BARDA Project NextGen Award Valued at up to $338 Million to Advance Intranasal NDV-based COVID-19 Booster Vaccine into Phase 2b Clinical Efficacy Testing
Florian Krammer, Peter Palese, Judith Aberg, Weina Sun & Sean T.H. Liu
17/10/23
1 item of Media coverage
Press/Media